TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00173316 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03703466 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03703466 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02261779 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT03038750 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study NCT03038750 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT03038750 — Predictive Biomarker (PRD): PROCR mRNA
Genes: PROCR; EPCR
Study NCT00003172 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02671045 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02671045 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00951301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00951301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03200054 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02558387 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02558387 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT00385580 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02463071 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03428022 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03428022 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03457493 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04420468 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01245387 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02616744 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01423851 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT01423851 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT02525250 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03694613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03694613 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03694613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00133380 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00133380 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04409275 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00353834 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00353834 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00353834 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00353834 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02973087 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00656773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04588545 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01817751 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00514163 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT00514163 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01537536 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02330822 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01266486 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT03896373 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT03896373 — Predictive Biomarker (PRD): FCGRT mRNA
Genes: FCGRT; FCRN
Study NCT03778853 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03062592 — Predictive Biomarker (PRD): FFAR1 mRNA
Genes: FFAR1; GPR40
Study NCT03062592 — Predictive Biomarker (PRD): FFAR4 mRNA
Genes: FFAR4; GPR120; GPR129; O3FAR1; PGR4
Study NCT03062592 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00745693 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02874365 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02874365 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT03819595 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03819595 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01814111 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01671813 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01038804 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01038804 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02346123 — Predictive Biomarker (PRD): LGALS3 mRNA
Genes: LGALS3; MAC2
Study NCT02346123 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study NCT02346123 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT01730599 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT02558673 — Predictive Biomarker (PRD): FMO3 mRNA
Genes: FMO3
Study NCT04532385 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03919669 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00504725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03317925 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03974399 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03974399 — Safety Biomarker (SAF): BDNF
Study NCT00437502 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04641299 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04641299 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03028051 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02062944 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT01817907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03580239 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04567927 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03026842 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT03026842 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study NCT04575168 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01976520 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02278562 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT02278562 — Safety Biomarker (SAF): Interleukin 1
Study NCT03728257 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03699228 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04513665 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04603885 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04457180 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01713842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01713842 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02290392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01681550 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01681550 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01192035 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00058552 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05805943 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03589495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01978834 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00943891 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT00865683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01436136 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01835925 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01299376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02428543 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02428543 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT02428543 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT02428543 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT02428543 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02428543 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT04195854 — Predictive Biomarker (PRD): P4HB mRNA
Genes: P4HB; ERBA2L; PDI; PDIA1; PO4DB
Study NCT03920553 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04183283 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT00517322 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01280448 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study NCT01280448 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01280448 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT01280448 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01280448 — Predictive Biomarker (PRD): ATP7A mRNA
Genes: ATP7A; MC1; MNK
Study NCT01280448 — Predictive Biomarker (PRD): ATP7B mRNA
Genes: ATP7B; PWD; WC1; WND
Study NCT01280448 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03396341 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03686098 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01943513 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT00396994 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00136526 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT01622192 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01656421 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04639635 — Predictive Biomarker (PRD): CNGB1 mRNA
Genes: CNGB1; CNCG2; CNCG3L; CNCG4; RCNC2
Study NCT02296671 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00838292 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00907751 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT03576794 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01638260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03182699 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05400681 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05400681 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05400681 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01345747 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00003784 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT02800668 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01375140 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT01375140 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04967781 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01103076 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01103076 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study NCT02747355 — Predictive Biomarker (PRD): MCM3 mRNA
Genes: MCM3
Study NCT02747355 — Predictive Biomarker (PRD): MCM2 mRNA
Genes: MCM2; BM28; CCNL1; CDCL1; KIAA0030
Study NCT02747355 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02747355 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT03093753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00502346 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04339764 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03632590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00317720 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03583983 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04700592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01607580 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04444401 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04435288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04402970 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04521413 — Predictive Biomarker (PRD): MAP4K1 mRNA
Genes: MAP4K1; HPK1
Study NCT00701883 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03493087 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT01436084 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT01436084 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02796313 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00856960 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00856960 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00906568 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00906568 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03755570 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01260194 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05029167 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04206072 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04206072 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03862807 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03657628 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04453436 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03022331 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT03345823 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study NCT00000536 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00331695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT03588988 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01934062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02108860 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02423551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02423551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00729378 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02549430 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02465983 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02644603 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT00768196 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT02650999 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02114411 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03241680 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03938766 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02965339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT02965339 — Predictive Biomarker (PRD): VCAM1 mRNA
Genes: VCAM1
Study NCT02965339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00636675 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03561103 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01423747 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT03173560 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00478933 — Predictive Biomarker (PRD): GNB3 mRNA
Genes: GNB3
Study NCT02865018 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT01456650 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study NCT02883075 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study NCT02883075 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04392388 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04353284 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00903409 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02374931 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT00474396 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02572596 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05749770 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00122681 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00361868 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02665299 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02689284 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02057796 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01683279 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04159142 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04159142 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02508467 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT01915498 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04456868 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT01265615 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT00758225 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04329351 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT04329351 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT04329351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04329351 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study NCT00659620 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02702492 — Predictive Biomarker (PRD): PAK4 mRNA
Genes: PAK4; KIAA1142
Study NCT02702492 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study NCT00713479 — Safety Biomarker (SAF): DRD2
Study NCT00004070 — Safety Biomarker (SAF): Interleukin 12
Study NCT01904292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02239393 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01357382 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01357382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01357382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01002872 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00972348 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02825355 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT01341665 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00643058 — Predictive Biomarker (PRD): NOS2 mRNA
Genes: NOS2; NOS2A
Study NCT02961023 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04622332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03051282 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03735875 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02140333 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00073528 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00073528 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00073528 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00073528 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02467283 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04021810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02039804 — Safety Biomarker (SAF): Hyaluronic acid